首页 > 最新文献

Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan最新文献

英文 中文
Laser-induced ocular injury: a narrative review 激光致眼损伤:一个叙事回顾
E. Wong, A. Lai, R. F. Lam, F. Lai
There is an increasing trend of reported laser-induced ocular injury. We aimed to review theliterature on the basic principles of laser, clinical management and safety precaution of laser-induced ocular injury. A literature search on the PubMed database was conducted to include articles dated up to April 2020. One example case of laser-induced ocular injury is provided. Clinical presentation of laser-induced ocular injury is variable. The clinical features can be transient and subtle. Appropriate investigations are useful to establish a diagnosis and to evaluate the severity of the injury. Laser-induced ocular injury most commonly involves the macula, which can be complicated by intraocular haemorrhage, macular hole, epiretinal membrane, and choroidal neovascularization. There are currently no evidence-based or well-recognized treatments for laser-induced retinopathy. Surgical intervention might be considered if there is significant intraocular hemorrhage or macular hole. Laser-induced ocular injury may cause permanent visual sequelae and functional disability. Diagnosis of an eye injury should be supported by objective clinical findings and/or appropriate investigations. As medical and surgical treatment options are currently limited, the key to combat laser ocular injuries lies in prevention and awareness of the general public should be reinforced.
激光致眼部损伤的报道呈上升趋势。本文就激光致眼损伤的基本原理、临床处理及安全预防等方面的文献作一综述。对PubMed数据库进行了文献检索,包括截止到2020年4月的文章。提供了一例激光引起的眼部损伤。激光致眼损伤的临床表现多种多样。临床特征可能是短暂而微妙的。适当的检查有助于诊断和评估损伤的严重程度。激光引起的眼部损伤最常累及黄斑,可并发眼内出血、黄斑孔、视网膜前膜和脉络膜新生血管。目前尚无基于证据或公认的治疗激光视网膜病变的方法。如果有明显的眼内出血或黄斑孔,可考虑手术干预。激光引起的眼部损伤可引起永久性视力后遗症和功能障碍。眼损伤的诊断应以客观的临床表现和/或适当的调查为依据。由于目前医疗和手术治疗选择有限,对抗激光眼损伤的关键在于预防和提高公众的认识。
{"title":"Laser-induced ocular injury: a narrative review","authors":"E. Wong, A. Lai, R. F. Lam, F. Lai","doi":"10.12809/hkjo-v24n2-278","DOIUrl":"https://doi.org/10.12809/hkjo-v24n2-278","url":null,"abstract":"There is an increasing trend of reported laser-induced ocular injury. We aimed to review theliterature on the basic principles of laser, clinical management and safety precaution of laser-induced ocular injury. A literature search on the PubMed database was conducted to include articles dated up to April 2020. One example case of laser-induced ocular injury is provided. Clinical presentation of laser-induced ocular injury is variable. The clinical features can be transient and subtle. Appropriate investigations are useful to establish a diagnosis and to evaluate the severity of the injury. Laser-induced ocular injury most commonly involves the macula, which can be complicated by intraocular haemorrhage, macular hole, epiretinal membrane, and choroidal neovascularization. There are currently no evidence-based or well-recognized treatments for laser-induced retinopathy. Surgical intervention might be considered if there is significant intraocular hemorrhage or macular hole. Laser-induced ocular injury may cause permanent visual sequelae and functional disability. Diagnosis of an eye injury should be supported by objective clinical findings and/or appropriate investigations. As medical and surgical treatment options are currently limited, the key to combat laser ocular injuries lies in prevention and awareness of the general public should be reinforced.","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46782662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Frontalis suspension surgery for blepharospasm with apraxia of eyelid opening: a case report 额肌悬吊术治疗眼睑痉挛伴开睑失用症1例
J. Chan, H. Yuen
An 86-year-old man presented with benign essential blepharospasm with apraxia of eyelid opening unresponsive to botulinum toxin type A treatment. He was successfully treated with bilateral frontalis suspension with upper blepharoplasty. Postoperatively, he was able to open his eyes without difficulty and resume his daily activities.
一位86岁的男性,表现为良性原发性眼睑痉挛,眼睑开放失用症,对A型肉毒杆菌毒素治疗无反应。他成功地接受了双侧额肌悬吊术和上睑成形术的治疗。术后,他能够毫无困难地睁开眼睛,恢复日常活动。
{"title":"Frontalis suspension surgery for blepharospasm with apraxia of eyelid opening: a case report","authors":"J. Chan, H. Yuen","doi":"10.12809/HKJO-V24N1-246","DOIUrl":"https://doi.org/10.12809/HKJO-V24N1-246","url":null,"abstract":"An 86-year-old man presented with benign essential blepharospasm with apraxia of eyelid opening unresponsive to botulinum toxin type A treatment. He was successfully treated with bilateral frontalis suspension with upper blepharoplasty. Postoperatively, he was able to open his eyes without difficulty and resume his daily activities.","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":"24 1","pages":"15-17"},"PeriodicalIF":0.0,"publicationDate":"2020-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45467579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Report on the 33rd Asia-Pacific Academy of Ophthalmology Congress, Hong Kong, 8-11 February 2018 第33届亚太眼科学会大会报告,香港,2018年2月8日至11日
C. K. Chan, C. Tham
{"title":"Report on the 33rd Asia-Pacific Academy of Ophthalmology Congress, Hong Kong, 8-11 February 2018","authors":"C. K. Chan, C. Tham","doi":"10.12809/HKJO-V24N1-265","DOIUrl":"https://doi.org/10.12809/HKJO-V24N1-265","url":null,"abstract":"","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":"24 1","pages":"22-24"},"PeriodicalIF":0.0,"publicationDate":"2020-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42430650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Retinoblastoma in Hong Kong from 2008 to 2019: looking back and moving forward 香港2008至2019年视网膜母细胞瘤回顾与展望
E. Wong, A. Chan, C. P. Lam, W. W. Lau, J. C. Yam, C. Yu
Purpose: To report the incidence, clinical features, and treatment outcomes of retinoblastoma at a tertiary referral center in Hong Kong.Methods: Medical records of all patients with retinoblastoma presenting to Hong Kong Eye Hospital from 2008 to 2019 were reviewed.Results: 75 eyes in 55 patients were treated for retinoblastoma during the 10-year study period. The mean age at presentation was 19.8±16.4 months. The mean duration of symptoms before diagnosis was 1.1±2.1 months. The most common presenting sign was leukocoria and/or strabismus (n=33, 60.1%). 65% of patients presented with advanced disease of groups D and E. The tumor was unilateral (n=35, 63.6%), bilateral (n=18, 32.7%), or trilateral (n=2, 3.6%). The enucleation rate was 0% in groups A to C, 70% in group D, and 93.3% in group E. With the introduction of intra-arterial chemotherapy since 2016, the globe salvage rate has increased from 29.4% to 33.3% in group D eyes and from 4.5% to 12.5% in group E eyes. The overall globe salvage rate was 40.0%, and the overall 5-year survival rate was 100%.Conclusions: The prognosis of retinoblastoma is good in cases with early detection and appropriate treatment. Unfortunately, most patients presented with relatively advanced disease, which lowers the overall globe salvage rate. There is a need for enhanced public awareness and education for healthcare professionals to facilitate early detection and improve ocular outcomes for children with retinoblastoma.
目的:报道香港某三级转诊中心视网膜母细胞瘤的发病率、临床特点和治疗结果。方法:回顾2008年至2019年香港眼科医院所有视网膜母细胞瘤患者的医疗记录。结果:在10年的研究期间,55例患者75只眼接受了视网膜母细胞瘤治疗。平均发病年龄19.8±16.4个月。诊断前症状的平均持续时间为1.1±2.1个月。最常见的症状是白斑和/或斜视(n=33, 60.1%)。D组和e组中65%的患者表现为晚期疾病。肿瘤为单侧(n=35, 63.6%)、双侧(n=18, 32.7%)或三边(n=2, 3.6%)。A ~ C组的眼球去核率为0%,D组为70%,E组为93.3%。2016年以来,随着动脉内化疗的引入,D组眼的整体挽救率从29.4%上升到33.3%,E组眼从4.5%上升到12.5%。总体全球救助率为40.0%,总体5年生存率为100%。结论:视网膜母细胞瘤早期发现,治疗得当,预后良好。不幸的是,大多数患者表现为相对晚期的疾病,这降低了整体的全球挽救率。有必要提高公众意识,并对保健专业人员进行教育,以促进视网膜母细胞瘤儿童的早期发现和改善视力结果。
{"title":"Retinoblastoma in Hong Kong from 2008 to 2019: looking back and moving forward","authors":"E. Wong, A. Chan, C. P. Lam, W. W. Lau, J. C. Yam, C. Yu","doi":"10.12809/HKJO-V24N1-270","DOIUrl":"https://doi.org/10.12809/HKJO-V24N1-270","url":null,"abstract":"Purpose: To report the incidence, clinical features, and treatment outcomes of retinoblastoma at a tertiary referral center in Hong Kong.\u0000Methods: Medical records of all patients with retinoblastoma presenting to Hong Kong Eye Hospital from 2008 to 2019 were reviewed.\u0000Results: 75 eyes in 55 patients were treated for retinoblastoma during the 10-year study period. The mean age at presentation was 19.8±16.4 months. The mean duration of symptoms before diagnosis was 1.1±2.1 months. The most common presenting sign was leukocoria and/or strabismus (n=33, 60.1%). 65% of patients presented with advanced disease of groups D and E. The tumor was unilateral (n=35, 63.6%), bilateral (n=18, 32.7%), or trilateral (n=2, 3.6%). The enucleation rate was 0% in groups A to C, 70% in group D, and 93.3% in group E. With the introduction of intra-arterial chemotherapy since 2016, the globe salvage rate has increased from 29.4% to 33.3% in group D eyes and from 4.5% to 12.5% in group E eyes. The overall globe salvage rate was 40.0%, and the overall 5-year survival rate was 100%.\u0000Conclusions: The prognosis of retinoblastoma is good in cases with early detection and appropriate treatment. Unfortunately, most patients presented with relatively advanced disease, which lowers the overall globe salvage rate. There is a need for enhanced public awareness and education for healthcare professionals to facilitate early detection and improve ocular outcomes for children with retinoblastoma.","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47974549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A new beginning for the Hong Kong Journal of Ophthalmology, the official journal of the College of Ophthalmologists of Hong Kong 香港眼科学院的官方刊物《香港眼科杂志》迎来崭新的开始
A. Kwok
{"title":"A new beginning for the Hong Kong Journal of Ophthalmology, the official journal of the College of Ophthalmologists of Hong Kong","authors":"A. Kwok","doi":"10.12809/hkjo-v24n1-277","DOIUrl":"https://doi.org/10.12809/hkjo-v24n1-277","url":null,"abstract":"","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":"24 1","pages":"5-5"},"PeriodicalIF":0.0,"publicationDate":"2020-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44162065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcomes of free internal limiting membrane transplant for unclosed macular holes after extensive internal limiting membrane peeling and silicone oil tamponade: a report of two cases 广泛剥除内限制膜并硅油填塞后游离内限制膜移植治疗未闭黄斑孔的远期疗效:附2例报告
A. Kwok
We report the long-term outcome of two cases of free internal limiting membrane (ILM) transplant for unclosed macular holes after extensive internal limiting membrane peeling and silicone oil tamponade. Free ILM graft was harvested and then successfully tucked against the inner edges of the macular hole in two eyes. All macular holes closed. In one case, the ILM filled the macular hole 100% in all meridians and remained closed 7 years after surgery. In another case, the ILM filled the gap of the macular hole 100% in the horizontal meridian and approximately 70% in the vertical meridian and re-opened 5 weeks after surgery. Filling the entire macular hole area with the ILM graft may improve long-term anatomical outcomes.
我们报告了两例游离内限制膜(ILM)移植治疗未封闭黄斑孔后广泛内限制膜剥离和硅油填塞的长期结果。取下游离ILM移植物,然后成功地将其塞在两只眼睛的黄斑孔的内边缘。所有黄斑孔闭合。在一个病例中,ILM在所有经络中100%填充黄斑孔,并在手术后7年保持闭合。在另一个病例中,ILM在水平经络上填充了100%的黄斑孔间隙,在垂直经络上填充了大约70%,并在手术后5周重新开放。用ILM移植物填充整个黄斑孔区域可以改善长期解剖结果。
{"title":"Long-term outcomes of free internal limiting membrane transplant for unclosed macular holes after extensive internal limiting membrane peeling and silicone oil tamponade: a report of two cases","authors":"A. Kwok","doi":"10.12809/HKJO-V24N1-267","DOIUrl":"https://doi.org/10.12809/HKJO-V24N1-267","url":null,"abstract":"We report the long-term outcome of two cases of free internal limiting membrane (ILM) transplant for unclosed macular holes after extensive internal limiting membrane peeling and silicone oil tamponade. Free ILM graft was harvested and then successfully tucked against the inner edges of the macular hole in two eyes. All macular holes closed. In one case, the ILM filled the macular hole 100% in all meridians and remained closed 7 years after surgery. In another case, the ILM filled the gap of the macular hole 100% in the horizontal meridian and approximately 70% in the vertical meridian and re-opened 5 weeks after surgery. Filling the entire macular hole area with the ILM graft may improve long-term anatomical outcomes.","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":"24 1","pages":"18-21"},"PeriodicalIF":0.0,"publicationDate":"2020-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43568761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of atropine treatment for slowing myopia progression in children: a 5-year review 阿托品治疗减缓儿童近视进展的安全性和有效性:一项5年回顾
Charles Lau, D. S. Fan, Kenneth K. W. Li
Aim: To report the efficacy and safety of atropine treatment (0.01% and 0.125%) in slowing myopia progression in children.Methods: This is a retrospective non-interventional case series. All patients aged <18 years who received topical atropine for myopia control from 2011 to 2016 in the Hong Kong Sanatorium & Hospital were included for analysis. Myopia progression, atropine treatment, and other factors affecting treatment outcomes were analyzed. We also reported any adverse effects associated with atropine use.Results: A total of 346 patients were recruited, with mean a follow-up period of 2.26±0.82 years. The patients had a mean reduction of myopia progression of 68.4% after atropine treatment (p<0.001). The mean myopia progression rate (in spherical equivalent) was -0.38±0.36 D/year, and the mean axial length elongation rate was 0.23±0.19 mm/year. More reduction of myopia progression was associated with baseline myopia progression of <-1 D/year (p<0.001) and initial atropine dosage of 0.125% (p<0.001). Reduction of myopiaprogression was associated with starting age (p=0.041) and baseline myopia progression (p=0.004). Patients aged <6 years who received atropine treatment (n=17) showed reduction of myopia progression by 71.1%. Only mild adverse effects such as photophobia were reported.Conclusion: Topical atropine is an efficacious and safe treatment for slowing myopia progression.
目的:报道阿托品治疗(0.01%和0.125%)在减缓儿童近视进展中的有效性和安全性。方法:这是一个回顾性的非介入病例系列。纳入2011年至2016年在香港疗养院医院接受局部阿托品控制近视的所有年龄<18岁的患者进行分析。分析近视进展、阿托品治疗及其他影响治疗结果的因素。我们还报告了与阿托品使用相关的任何不良反应。结果:共招募346例患者,平均随访时间为2.26±0.82年。患者在阿托品治疗后近视进展平均减少68.4% (p<0.001)。平均近视进展率(以球面等效)为-0.38±0.36 D/年,平均眼轴长度延长率为0.23±0.19 mm/年。近视进展的进一步减少与基线近视进展<-1 D/年(p<0.001)和初始阿托品剂量0.125% (p<0.001)相关。近视进展的减少与起始年龄(p=0.041)和基线近视进展(p=0.004)相关。接受阿托品治疗的<6岁患者(n=17)近视进展减少71.1%。仅报道了轻微的不良反应,如畏光。结论:局部使用阿托品治疗近视是一种安全有效的治疗方法。
{"title":"Safety and efficacy of atropine treatment for slowing myopia progression in children: a 5-year review","authors":"Charles Lau, D. S. Fan, Kenneth K. W. Li","doi":"10.12809/HKJO-V24N1-255","DOIUrl":"https://doi.org/10.12809/HKJO-V24N1-255","url":null,"abstract":"Aim: To report the efficacy and safety of atropine treatment (0.01% and 0.125%) in slowing myopia progression in children.\u0000Methods: This is a retrospective non-interventional case series. All patients aged <18 years who received topical atropine for myopia control from 2011 to 2016 in the Hong Kong Sanatorium & Hospital were included for analysis. Myopia progression, atropine treatment, and other factors affecting treatment outcomes were analyzed. We also reported any adverse effects associated with atropine use.\u0000Results: A total of 346 patients were recruited, with mean a follow-up period of 2.26±0.82 years. The patients had a mean reduction of myopia progression of 68.4% after atropine treatment (p<0.001). The mean myopia progression rate (in spherical equivalent) was -0.38±0.36 D/year, and the mean axial length elongation rate was 0.23±0.19 mm/year. More reduction of myopia progression was associated with baseline myopia progression of <-1 D/year (p<0.001) and initial atropine dosage of 0.125% (p<0.001). Reduction of myopiaprogression was associated with starting age (p=0.041) and baseline myopia progression (p=0.004). Patients aged <6 years who received atropine treatment (n=17) showed reduction of myopia progression by 71.1%. Only mild adverse effects such as photophobia were reported.\u0000Conclusion: Topical atropine is an efficacious and safe treatment for slowing myopia progression.","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46643770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Challenges that lie ahead 未来的挑战
I. Wong
It has been my greatest honor and pleasure to have taken up the office of the Editor-in-Chief of the Hong Kong Journal of Ophthalmology (HKJO) since 2015. During the past two terms of service, we have seen leaps forward for our Journal. Some areas have had a facelift. For instance, HKJO has found its new home at hkjo.hk. Not only has this increased accessibility, it has also enabled authors to submit their manuscripts online. Since the launch of the website, HKJO has received 8362 visits from all over the world (as of 15 March 2019), including from the United States, India, China, the United Kingdom, Russia, and Singapore. Most visitors to the website are from Hong Kong (constituting around 30% of all visits), followed by the United States (11.8%) and India (7.5%) [Table and Figure]. We have also received submissions from different parts of the world. The original goal of setting up the website was to enhance international exposure of HKJO and to encourage submissions from outside of Hong Kong. I believe we have successfully achieved this goal. Although the setting up of the website was challenging, it was clearly the right decision. I wish to thank the Council of the College of Ophthalmologists of Hong Kong for endorsing this endeavor and for providing financial support. I would also like to acknowledge Dr Alvin Au Ka Hong for designing and setting up the website, and for providing technical support throughout the years.
自2015年起担任香港眼科杂志主编,我感到非常荣幸和愉快。在过去的两个任期内,我们看到《华尔街日报》取得了长足的进步。一些地区进行了整容手术。例如,HKJO在HKJO.hk找到了新家,这不仅增加了可访问性,还使作者可以在网上提交稿件。自网站推出以来,HKJO已收到来自世界各地的8362次访问(截至2019年3月15日),包括来自美国、印度、中国、英国、俄罗斯和新加坡的访问。该网站的大多数访问者来自香港(约占所有访问者的30%),其次是美国(11.8%)和印度(7.5%)[表和图]。我们还收到了来自世界各地的意见书。设立该网站的最初目的是提高香港联合办事处在国际上的知名度,并鼓励香港以外的地方提交资料。我相信我们已经成功地实现了这一目标。尽管网站的建立具有挑战性,但这显然是一个正确的决定。我要感谢香港眼科学院理事会支持这项工作并提供财政支持。我还要感谢欧家康博士多年来设计和建立该网站,并提供技术支持。
{"title":"Challenges that lie ahead","authors":"I. Wong","doi":"10.12809/HKJO-V23N1-EDITORIAL","DOIUrl":"https://doi.org/10.12809/HKJO-V23N1-EDITORIAL","url":null,"abstract":"It has been my greatest honor and pleasure to have taken up the office of the Editor-in-Chief of the Hong Kong Journal of Ophthalmology (HKJO) since 2015. During the past two terms of service, we have seen leaps forward for our Journal. Some areas have had a facelift. For instance, HKJO has found its new home at hkjo.hk. Not only has this increased accessibility, it has also enabled authors to submit their manuscripts online. Since the launch of the website, HKJO has received 8362 visits from all over the world (as of 15 March 2019), including from the United States, India, China, the United Kingdom, Russia, and Singapore. Most visitors to the website are from Hong Kong (constituting around 30% of all visits), followed by the United States (11.8%) and India (7.5%) [Table and Figure]. We have also received submissions from different parts of the world. The original goal of setting up the website was to enhance international exposure of HKJO and to encourage submissions from outside of Hong Kong. I believe we have successfully achieved this goal. Although the setting up of the website was challenging, it was clearly the right decision. I wish to thank the Council of the College of Ophthalmologists of Hong Kong for endorsing this endeavor and for providing financial support. I would also like to acknowledge Dr Alvin Au Ka Hong for designing and setting up the website, and for providing technical support throughout the years.","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41701072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasolacrimal sac metastasis from colorectal carcinoma: a case report 结直肠癌鼻泪囊转移1例
C. Lam, S. C. Lam, W. Cheuk, H. Yuen
We report a rare case of metastasis to the nasolacrimal sac from colorectal carcinoma in a 69-year old man. Despite tumor removal and endoscopic dacryocystorhinostomy with stenting, the tumor recurred 3 months later, which was treated with chemotherapy and radiotherapy. Five months later, the patient eventually died from respiratory failure secondary to malignant pleural effusion.
我们报告一位69岁男性结直肠癌转移至鼻泪囊的罕见病例。虽行肿瘤切除及内镜下泪囊鼻腔造口支架术,但3个月后肿瘤复发,经化疗及放疗治疗。5个月后,患者最终死于恶性胸腔积液引起的呼吸衰竭。
{"title":"Nasolacrimal sac metastasis from colorectal carcinoma: a case report","authors":"C. Lam, S. C. Lam, W. Cheuk, H. Yuen","doi":"10.12809/HKJO-V23N1-254","DOIUrl":"https://doi.org/10.12809/HKJO-V23N1-254","url":null,"abstract":"We report a rare case of metastasis to the nasolacrimal sac from colorectal carcinoma in a 69-year old man. Despite tumor removal and endoscopic dacryocystorhinostomy with stenting, the tumor recurred 3 months later, which was treated with chemotherapy and radiotherapy. Five months later, the patient eventually died from respiratory failure secondary to malignant pleural effusion.","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47580051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Alcohol-assisted epithelial debridement for treatment of recurrent corneal erosion: a case series 酒精辅助上皮清创治疗复发性角膜糜烂:一个病例系列
L. Cheng, V. Chow, B. Yiu
Purpose: Recurrent corneal erosion is characterized by recurrent episodes of spontaneous breakdown of the corneal epithelium. Alcohol delamination of the corneal epithelium has a high success rate, but the procedure requires the use of an operating microscope in an operating theater. We present a case series of alcohol assisted epithelial debridement in the clinic setting. Methods: Records of eight consecutive patients aged >18 years who presented to a private ophthalmology practice clinic in Hong Kong between October 2012 and March 2018 with recurrent corneal erosion that did not respond well to conservative or surgical management with persistent symptoms of >3 months were retrospectively reviewed. 75% alcohol was applied directly to the site of abnormal epithelium under slit lamp, followed by debridement of the epithelium using a surgical sponge. A bandage contact lens was then inserted. Patients were followed up until complete healing of the epithelial defect. Results: All eight patients achieved complete healing of the epithelial defect within 2 weeks with no major complication or recurrence. Conclusion: Alcohol-assisted epithelial debridement is simple, safe, and effective for the treatment of recurrent corneal erosion. It can be performed in a clinic setting under slit lamp.
目的:复发性角膜侵蚀的特点是反复发作的角膜上皮自发破裂。角膜上皮的酒精分层成功率很高,但该手术需要在手术室使用手术显微镜。我们介绍了一系列临床应用酒精辅助上皮清创术的病例。方法:回顾性分析2012年10月至2018年3月期间在香港私立眼科诊所就诊的8名年龄>18岁的连续患者的记录,这些患者患有复发性角膜糜烂,对保守治疗或手术治疗反应不佳,症状持续>3个月。在裂隙灯下将75%的酒精直接应用于异常上皮部位,然后使用外科海绵对上皮进行清创。然后插入绷带隐形眼镜。对患者进行随访,直到上皮缺损完全愈合。结果:8例患者均在2周内完成了上皮缺损的完全愈合,无重大并发症或复发。结论:酒精辅助上皮清创术治疗复发性角膜糜烂简单、安全、有效。它可以在裂隙灯下的诊所环境中进行。
{"title":"Alcohol-assisted epithelial debridement for treatment of recurrent corneal erosion: a case series","authors":"L. Cheng, V. Chow, B. Yiu","doi":"10.12809/HKJO-V23N1-253","DOIUrl":"https://doi.org/10.12809/HKJO-V23N1-253","url":null,"abstract":"Purpose: Recurrent corneal erosion is characterized by recurrent episodes of spontaneous breakdown of the corneal epithelium. Alcohol delamination of the corneal epithelium has a high success rate, but the procedure requires the use of an operating microscope in an operating theater. We present a case series of alcohol assisted epithelial debridement in the clinic setting. Methods: Records of eight consecutive patients aged >18 years who presented to a private ophthalmology practice clinic in Hong Kong between October 2012 and March 2018 with recurrent corneal erosion that did not respond well to conservative or surgical management with persistent symptoms of >3 months were retrospectively reviewed. 75% alcohol was applied directly to the site of abnormal epithelium under slit lamp, followed by debridement of the epithelium using a surgical sponge. A bandage contact lens was then inserted. Patients were followed up until complete healing of the epithelial defect. Results: All eight patients achieved complete healing of the epithelial defect within 2 weeks with no major complication or recurrence. Conclusion: Alcohol-assisted epithelial debridement is simple, safe, and effective for the treatment of recurrent corneal erosion. It can be performed in a clinic setting under slit lamp.","PeriodicalId":90844,"journal":{"name":"Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48381334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hong Kong journal of ophthalmology : the official publication of the College of Ophthalmologists of Hong Kong = Xianggang yan ke xue kan : Xianggang yan ke yi xue yuan
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1